Diagnostics growth drives Zoetis' latest acquisitionFebruary 14, 2020Four months after venturing into the world of reference laboratory services, Zoetis has bolstered its presence within the space through the acquisition of Ethos Diagnostic Science.
SPONSORED CONTENTHELP THEM FEEL COMFORTABLE IN THEIR OWN SKIN.Could the key to managing the constant itching and inflammation of canine atopic dermatitis be at the bottom of a bowl? + Learn More
Zoetis expands diagnostics capabilities with ZNLabs acquisitionNovember 27, 2019Zoetis has strengthened its diagnostics portfolio with the acquisition of ZNLabs, a full-service veterinary clinical reference laboratory company.
Zoetis strengthens diagnostics services through acquisitionNovember 1, 2019Zoetis has thrown its hat into the ring of reference laboratory services with the acquisition of Phoenix Central Laboratory for Veterinarians.
American Humane recognizes veterinary heroesOctober 7, 2019Two animal health-care professionals were praised as heroes at the ninth annual American Humane Hero Dog Awards.
Zoetis scholarships reward excellence, leadershipOctober 2, 2019Zoetis and the Association of American Veterinary Medical Colleges (AAVMC) will partner once again in 2020 to provide scholarships to second- and third-year veterinary students in the U.S. and the Caribbean.
Zoetis, Purina, Merck team up for diabetes campaignAugust 30, 2019November is Pet Diabetes Month, and the Diabetes Pet Care Alliance is once again encouraging veterinarians to enroll their clinics in their program.
Veterinarians urged to discuss skin health with clientsJuly 30, 2019Recent years have seen a rash of skin conditions in pets, and Zoetis is urging animal health professionals to speak up on the issue.
Zoetis strengthens equine portfolio with acquisitionJuly 25, 2019Zoetis Inc., has entered into an agreement to purchase Platinum Performance. The acquisition aims to strengthen Zoetis’s nutritional offerings, particularly within the equine market.
FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
Zoetis becomes first Human-Animal Bond-certified companyMay 3, 2019Zoetis is the first company to become Human-Animal Bond certified. More than two dozen company employees completed the program, and were taught the science behind the human-animal bond. The employees were also shown how this science supports the practice of veterinary medicine. The certification program was created by the North American Veterinary Community (NAVC) and the Human Animal Bond Research Institute (HABRI). "For years, Zoetis has been a leading advocate of the bond between humans and animals, and we are honored to have earned this important certification," says Zoetis Petcare marketing executive director, J. Michael McFarland, DVM, DABVP, chair of the HABRI board of trustees. "Veterinarians play a key role in strengthening the relationship between animals and people, and Zoetis is committed to helping them, their clients, and the animals they care for experience the benefits of the human-animal bond." In its first year, more than 500 professionals have signed up for this certification, which offers 22 hours of RACE-approved continuing education credit. Zoetis also developed educational resources related to the program for its own employees, for the veterinary community, and for pet owners. "With its long-term commitment to funding human-animal bond research, education, professional development, and programming, Zoetis …
